|
|
|
|
Each of the major biologic manufacturing strategies — scale up, scale out, and continuous — presents specific advantages. As you consider the strategy that best pairs with your needs, examine a breakdown of each approach and the scenarios in which they excel before you select a path to commercialization.
|
|
|
|
|
Providing access to a well-established manufacturing network removes the risk of multiple tech transfers. Explore KojoX™, a uniform operating philosophy that when applied across sites, scales, and modalities, harmonizes facility layout and design, equipment, processes, and procedures through modular concepts.
|
|
|
|
|
As biopharma shortages continue to be a global concern, consider working with an innovative manufacturer to help alleviate challenges. If faced with uncertain demand forecasts, a CDMO that offers modular manufacturing and the ability to shift between continuous and large-scale platforms as needed can help ensure reliable delivery to patient.
|
|
|
|
|
The biopharmaceutical industry faces a multitude of challenges. Learn how a collaborative outsourcing partnership based on trust and transparency can foster efficient and high-quality drug production. With a new strategy, FDB set the global aspiration: To be the leading and most trusted Partner for Life in the biopharmaceutical industry.
|
|
|
|
|
|
|
|
|
|
|
